valproic acid has been researched along with agmatine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Borowicz, KK; Czernecki, R; Czuczwar, SJ; Luszczki, JJ; Wojtal, K | 1 |
Banerjee, S; Gonzales, ELT; Han, SH; Kim, JW; Kim, KC; Ko, MJ; Oh, HA; Seung, H; Shin, CY; Yang, SM | 1 |
Abo-Haded, H; Ahmed, N; Al-Hujaili, HS; Al-Hujaili, MA; Aljuhani, N; El-Agamy, DS; Elkablawy, MA; Noah, MM | 1 |
Bae, HJ; Chung, HJ; Gonzales, EL; Jeon, SJ; Kim, DH; Kim, J; Kwon, H; Ryu, JH; Shin, CY | 1 |
5 other study(ies) available for valproic acid and agmatine
Article | Year |
---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Agmatine enhances the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock seizure model.
Topics: Agmatine; Animals; Anticonvulsants; Avoidance Learning; Drug Interactions; Drug Synergism; Electroshock; Hand Strength; Male; Mice; Muscle Strength; Phenobarbital; Postural Balance; Psychomotor Performance; Seizures; Valproic Acid | 2008 |
Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism.
Topics: Agmatine; Animals; Autism Spectrum Disorder; Disease Models, Animal; Grooming; Hippocampus; Hyperkinesis; Male; MAP Kinase Signaling System; Mice; Mice, Transgenic; Neural Stem Cells; Neurons; Prefrontal Cortex; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Seizures; Social Behavior; Valproic Acid | 2017 |
Agmatine protects against sodium valproate-induced hepatic injury in mice via modulation of nuclear factor-κB/inducible nitric oxide synthetase pathway.
Topics: Agmatine; Alanine Transaminase; Alkaline Phosphatase; Animals; Anticonvulsants; Antioxidants; Aspartate Aminotransferases; Biomarkers; Chemical and Drug Induced Liver Injury; Cytokines; gamma-Glutamyltransferase; Inflammation Mediators; L-Lactate Dehydrogenase; Liver; Male; Mice; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Valproic Acid | 2018 |
Agmatine relieves behavioral impairments in Fragile X mice model.
Topics: Agmatine; Animals; Calcium Carbonate; Disease Models, Animal; Fragile X Mental Retardation Protein; Fragile X Syndrome; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Polyamines; Valproic Acid | 2022 |